Linagliptin
Linagliptin is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
| Catalog Number | T0191 |
| Alternative Name(s) | BI 1356 |
| Research Area | Proteases/Proteasome|||Ubiquitination|||Autophagy|||Apoptosis |
| Molecular Formula | C25H28N8O2 |
| CAS# | 668270-12-0 |
| Purity | 99.15% |
| SMILES | CC#CCn1c(nc2c1c(=O)n(Cc1nc3ccccc3c(C)n1)c(=O)n2C)N1CCC[C@@H](N)C1 |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/Linagliptin |
| Additional Information | https://www.targetmol.com/datasheet/T0191 |